Zacks: Brokerages Anticipate The Advisory Board Company (ABCO) Will Post Quarterly Sales of $202.29 Million
Brokerages expect The Advisory Board Company (NASDAQ:ABCO) to announce sales of $202.29 million for the current fiscal quarter, Zacks Investment Research reports. Ten analysts have issued estimates for The Advisory Board’s earnings, with the highest sales estimate coming in at $210.70 million and the lowest estimate coming in at $194.00 million. The Advisory Board reported sales of $200.46 million in the same quarter last year, which indicates a positive year over year growth rate of 0.9%. The firm is expected to report its next earnings report on Tuesday, November 7th.
On average, analysts expect that The Advisory Board will report full-year sales of $202.29 million for the current financial year, with estimates ranging from $792.87 million to $819.50 million. For the next financial year, analysts forecast that the firm will post sales of $845.76 million per share, with estimates ranging from $821.50 million to $862.00 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for The Advisory Board.
The Advisory Board (NASDAQ:ABCO) last issued its quarterly earnings data on Tuesday, August 8th. The business services provider reported $0.24 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.32 by ($0.08). The business had revenue of $200.30 million during the quarter, compared to the consensus estimate of $196.16 million. The Advisory Board had a return on equity of 12.69% and a net margin of 13.65%. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.46 earnings per share.
Several equities research analysts have issued reports on ABCO shares. Zacks Investment Research lowered shares of The Advisory Board from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 25th. William Blair lowered shares of The Advisory Board from an “outperform” rating to a “hold” rating in a research note on Tuesday, August 29th. Robert W. Baird lowered shares of The Advisory Board from an “outperform” rating to a “neutral” rating and lowered their price objective for the stock from $63.00 to $54.00 in a research note on Tuesday, August 29th. Stifel Nicolaus restated a “hold” rating and set a $53.00 price objective (up from $48.00) on shares of The Advisory Board in a research note on Thursday, July 6th. Finally, Cantor Fitzgerald restated a “hold” rating and set a $54.00 price objective (up from $45.00) on shares of The Advisory Board in a research note on Tuesday, August 29th. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have assigned a buy rating to the company’s stock. The Advisory Board currently has a consensus rating of “Hold” and an average price target of $51.95.
WARNING: This report was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/10/05/zacks-brokerages-anticipate-the-advisory-board-company-abco-will-post-quarterly-sales-of-202-29-million.html.
Several hedge funds have recently made changes to their positions in ABCO. UBS Asset Management Americas Inc. boosted its holdings in shares of The Advisory Board by 132.2% during the 1st quarter. UBS Asset Management Americas Inc. now owns 21,361 shares of the business services provider’s stock worth $1,000,000 after buying an additional 12,162 shares during the period. Karp Capital Management Corp bought a new stake in shares of The Advisory Board during the 1st quarter worth about $244,000. Parametric Portfolio Associates LLC boosted its holdings in shares of The Advisory Board by 83.8% during the 1st quarter. Parametric Portfolio Associates LLC now owns 140,822 shares of the business services provider’s stock worth $6,590,000 after buying an additional 64,207 shares during the period. Ameritas Investment Partners Inc. bought a new stake in shares of The Advisory Board during the 1st quarter worth about $166,000. Finally, Victory Capital Management Inc. bought a new stake in shares of The Advisory Board during the 1st quarter worth about $109,000.
Shares of The Advisory Board (NASDAQ ABCO) opened at 53.90 on Thursday. The firm’s 50-day moving average is $52.88 and its 200-day moving average is $51.60. The Advisory Board has a 12-month low of $24.85 and a 12-month high of $59.50. The company has a market capitalization of $2.19 billion, a PE ratio of 20.47 and a beta of 1.33.
The Advisory Board Company Profile
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related stocks with our FREE daily email newsletter.